ERBB2 and breast carcinoma: Recent studies have shown that omission of radiotherapy after BCS has no effect on OS or breast‐cancer‐specific survival (BCSS) in older breast cancer patients with HR‐positive, human epidermal growth factor receptor 2 (HER2)‐positive, and triple‐negative breast cancer (TNBC) subtypes.